-- 獨立研究機構CFRA向提供了以下研究報告。 CFRA分析師的觀點總結如下：Tempus AI公佈了2026年第一季財報，營收為3.481億美元（年成長36.1%），超出市場預期的3.45億美元。其中，診斷業務（2.611億美元，年成長34.7%）和數據與應用業務（8,700萬美元，年成長40.5%）均實現了強勁成長。調整後每股虧損0.13美元，顯著優於市場預期的0.20美元及去年同期的0.24美元。調整後EBITDA改善1,330萬美元至虧損280萬美元，調整後毛利率達65.0%（年增360個基點）。強勁的銷售成長包括腫瘤檢測業務成長28%，遺傳檢測業務在2025年第一季完成對Ambry Genetics的收購後成長54%（其中7%為內生成長），以及微小殘留病灶（MRD）檢測業務成長500%，達到6500例。鑑於業績遠超預期，TEM將2026年營收預期上調至15.9億美元至16億美元（約成長25%），同時維持調整後EBITDA預期為6,500萬美元。我們相信，TEM定於2026年5月29日舉行的首次投資者日活動將提供更多關於市場動態和長期增長預期的信息，從而支持公司實現持續盈利的目標。
Related Articles
Asia
Anteris Technologies Enrolls First US Patients in PARADIGM Trial; Shares Up 6%
Anteris Technologies (ASX:AVR) has enrolled and successfully treated the first US patients in its PARADIGM global pivotal trial of the DurAVR transcatheter heart valve for severe calcific aortic stenosis, according to a Wednesday Australian bourse filing.The procedures were carried out at Montefiore Medical Center in New York, the filing added.The company's shares rose 6% in recent Wednesday trade.
$ASX:AVR
Research
Research Alert: CFRA Maintains Hold Rating On Shares Of Ballard Power System Inc.
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We increase our target price from CAD4.20 to CAD6.40, applying a price-to-sales multiple of 13x our 2026 sales-per-share view (CAD0.49 using a USD/CAD exchange rate of 0.73x). We adjust our 2026 loss per share (LPS) estimate to -USD0.19 from -USD0.23 and our 2027 LPS view to -USD0.11 from -USD0.15. BLDP reported Q1 2026 revenue of USD19.4M, up 26% Y/Y, driven by strong growth in rail (up 4,472% to USD5.1M) and stationary power (up 775% to USD5.2M), though Bus revenue declined 46% to USD6.8M due to delivery timing and EU funding delays. Q1 results showed encouraging metrics, and we see potential upside from major design wins with Wrightbus and Solaris for next-generation hydrogen bus platforms and a multiyear 50 MW agreement with New Flyer. However, its declining backlog remains a concern. The 12-month order book declined 2% to USD52.8M, while the total backlog fell 5% to USD112.9M. We applaud improving gross margin trends, reflecting successful execution of its cost reduction initiatives.
$BLDP
Research
Research Alert: CFRA Maintains Hold Rating On Shares Of Ballard Power System Inc.
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We increase our target price from $3.00 to $4.70, applying a price-to-sales multiple of 13x our 2026 sales-per-share view of $0.36. We adjust our 2026 loss per share (LPS) estimate to -$0.19 from -$0.23 and our 2027 LPS view to -$0.11 from -$0.15. BLDP reported Q1 2026 revenue of $19.4M, up 26% Y/Y, driven by strong growth in rail (up 4,472% to $5.1M) and stationary power (up 775% to $5.2M), though Bus revenue declined 46% to $6.8M due to delivery timing and EU funding delays. Q1 results showed encouraging metrics, and we see potential upside from major design wins with Wrightbus and Solaris for next-generation hydrogen bus platforms and a multiyear 50 MW agreement with New Flyer. However, its declining backlog remains a concern. The 12-month order book declined 2% to $52.8M, while the total backlog fell 5% to $112.9M. We applaud improving gross margin trends, reflecting successful execution of its cost reduction initiatives.
$BLDP